Top five Alzheimer Disease trial eligibility criteria favor men compared to women in a clinic-based cohort

Journal of Prevention of Alzheimer's Disease · Published 2026-05-07 · DOI 10.1016/j.tjpad.2026.100580

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.tjpad.2026.100580

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2026

Related articles

Reductions in neuropsychiatric symptoms after lecanemab treatment and their associations with imaging markers of β-amyloid clearance · Journal of Prevention of Alzheimer's Disease · 2026 · Same journal
Combined effect of anxiety disorder and insomnia on the risk of incident ADRD diagnosis · Journal of Prevention of Alzheimer's Disease · 2026 · Same journal
Sex differences in subjective cognition among middle-aged and older Hispanic/Latino adults: Findings from the HCHS/SOL and SOL-INCA · Journal of Prevention of Alzheimer's Disease · 2026 · Same journal
Plasma brain-derived p-Tau217 outperforms other p-Tau species in detecting abnormal brain amyloid in an Asian cohort of older people with cerebrovascular disease burden · Journal of Prevention of Alzheimer's Disease · 2026 · Same journal
Suboptimal adherence to brain health recommendations in patients pursuing anti-amyloid antibody therapy for Alzheimer’s disease: Report from the Brain Health Vital Signs project · Journal of Prevention of Alzheimer's Disease · 2026 · Same journal
Depressive symptoms as a risk factor or prodrome of dementia: multi-state cognitive transitions modified by age and polygenic risk · Journal of Prevention of Alzheimer's Disease · 2026 · Same journal
Efficacy and safety of donanemab in the European eligible population: TRAILBLAZER-ALZ 2 post-hoc analyses · Journal of Prevention of Alzheimer's Disease · 2026 · Same journal
Tailored implementation of multidomain intervention to prevent cognitive impairment in community-dwelling older adults (Timi-Cog): A study protocol for a hybrid type 2 trial effectiveness-implementation study · Journal of Prevention of Alzheimer's Disease · 2026 · Same journal
Associations of plasma biomarkers with age in the presenilin-1 E280A autosomal dominant Alzheimer's disease kindred · Journal of Prevention of Alzheimer's Disease · 2026 · Same journal
Eligibility of men vs. women in Alzheimer’s trials: Inclusive vs. representative · Journal of Prevention of Alzheimer's Disease · 2026 · Same journal